中国药理学会分析药理学专业委员会

随着精准医学和转化医学的发展，药理学为了实现精准药物治疗和精准药物研发，需要从不同角度、不同维度研究药物与机体相互作用及其规律与机制，因此药理学研究需要与各种近期快速兴起的生命分析技术交叉，深入揭示药物分子与靶标分子交互作用的多维科学问题。分析药理学是一个新兴交叉领域，主要是围绕药理学的关键科学问题，发展生物分子检测与示踪新原理、新方法与新技术，对生物体内外活性分子进行特异、灵敏、快速地定性、定量检测，实现分子识别和生物信息提取,用于研究生物体系中各种成份、结构单元以及相互作用过程中的变化。分析药理学将汇聚化学、生物医学、生物工程、药学、计算机和药理学学科科技工作者的共同参与，通过现代分析技术等与药理学的交叉融合，搭建满足药理学发展需求的学术交流平台，促进药理学科的发展。

第二届中国药理学会分析药理学专业委员会

名誉主任委员：曾苏

主任委员：周国华

侯任主任委员：郝海平

副主任委员（按拼音字母排序）：

毕惠嫦，顾景凯，鞠熀先，刘杰，刘中秋，余露山

常务委员（按拼音字母排序）：

阿基业，郭非凡，洪学传，侯廷军，贾伟，姜长涛，李川，李清，梁琼麟，林厚文，罗成，谭敏佳，汪晖，王琰，武新安，燕茹，张健，张勇，张占军，赵荣生，肇丽梅，郑江，朱峰，邹秉杰

委员（按拼音字母排序）：

边诣聪，程妍，丁霖，葛广波，何芋岐，洪战英，胡泽平，黄凌，蒋善群，康玉，李飞，林江，林玲，刘利红，吕海涛，彭芳辰，钱玲慧，宋沁馨，孙立新，孙晓莲，谭嘉恒，谭志荣，唐斓，万建波，王海钠，吴宝剑，夏春华，夏洪平，向铮，肖易倍，肖玉秀，谢岑，谢莹，徐丹，徐骁，许风国，鄢丹，张东东，张海涛，张丽军，张楠，张倩茹，张彦民，郑恒，朱正江

秘书长：武海萍

副秘书长：叶慧

Division of Analytical Pharmacology，Chinese Pharmacological Society

As precision medicine and translational medicine keep evolving, there is need for pharmacology to study the laws and mechanisms of drug-organism interactions from novel paradigms and multiple dimensions, with the aim to accelerate precision drug research & development and achieve precision drug therapy. Hence pharmacology research needs to intersect with various analytical technologies which have been recent-rapidly emerging in life science to deeply reveal the multidimensional scientific insights of drug molecule-target molecule interactions. Analytical pharmacology is an emerging cross-field that focuses on the key scientific issues in pharmacology, i.e. developing novel principles, methods and technology for the detection and tracing of biomolecules, conducting qualitative and quantitative detection of active molecules in vivo and vitro in a more specific, sensitive and rapid manner, and facilitating the molecular identification and biological information extraction, for the study of variations from various components, structural units and interaction processes in biological systems. Analytical pharmacology will put together joint efforts of the scientists and engineers from multiple disciplines of Chemistry, Biomedicine, Bioengineering, Pharmacy, Computer Science and Pharmacology, to establish an academic hub merging with cutting-edge analytical technology, in order to promote the continuous development of pharmacology discipline.